Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8633019 Methods for treating spinal muscular atrophy

Patent 8633019 was granted and assigned to Ptc Therapeutics, Inc. on January, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Nikolai Naryshkin0

Charles Romfo0

Ellen Welch0

Sergey V. Paushkin0

Date of Patent

January 21, 2014

0

Patent Application Number

129945170

Date Filed

May 27, 2009

0

Patent Citations Received

US Patent 12103926 Compounds for treating huntington's disease

0

US Patent 11702646 Methods for modulating RNA splicing

0

US Patent 11753407 Compounds for treating spinal muscular atrophy

US Patent 11780839 Compounds for treating Huntington's disease

US Patent 11858941 Heterocyclic and heteroaryl compounds for treating Huntington's disease

0

US Patent 11964971 Methods and compositions for modulating splicing

0

Patent Primary Examiner

0

Patent abstract

The present invention provides nucleic acid constructs, methods for identifying and validating compounds that increase the inclusion of exon 7 of SMN2 into mRNA transcribed from the SMN2 gene, compounds and pharmaceutical compositions that increase levels of SMN protein produced from the SMN2 gene, and methods for use thereof in treating of SMA.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8633019 Methods for treating spinal muscular atrophy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool